Citichem India IPO, one of the upcoming IPOs, opened for subscription on December 27, 2024, and closed on December 31, 2024.
The company finalised share allotments yesterday, January 1, 2025. Successful bidders can expect the shares to be credited to their demat accounts today January 2, 2025. Those who did not receive an allotment will likely receive refunds on the same day. The stock is expected to debut on the BSE SME on Friday, January 3, 2025. You can check the allotment status on the BSE website or the registrar website, Kfin Technologies Limited.
This IPO is a fixed price issue amounting to ₹12.60 crores, comprising a fresh issue of 18.00 lakh shares.
The price for the Citichem India IPO was set at ₹70 per share, with a minimum application lot size of 2000 shares, requiring retail investors to invest at least ₹1,40,000.
The company intends to utilise the net proceeds from the fresh issue for capital expenditure for the acquisition of property; to purchase transportation vehicles and accessories; to meet the issue expenses and for general corporate purposes.
Citichem India IPO was of a total of 18,00,001 shares, with allocations of 8,54,000 (47.44%) to NIIs and 8,54,000 (47.44%) to Retail Individual Investors (RIIs).
On Day 3, December 31, 2024, the Citichem India IPO subscribed 414.35 times. The public issue was subscribed 543.18 times in the retail category and 277.88 times in the Non-Institutional Investors (NII) category.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
We're Live on WhatsApp! Join our channel for market insights & updates